NIH, with the University of California Biological Safety Officer’s Working Group, BioNet, and the Arizona Biosafety Alliance will be hosting the sixth in a series of public listening sessions to obtain stakeholder feedback on NIH’s effort to modernize and strengthen biosafety oversight.
Priority for providing oral comments at this meeting will be given to stakeholders located in: California, Arizona, Nevada, Oregon, Washington, Alaska, and Hawaii.
NIH Videocast
Draft Agenda
Listening Session 6 Draft Agenda
Meeting Flyer
Introductory Slides
Coming Soon
Public Comments
NIH and its partners encourage any interested individual to sign up to provide oral comments during the listening session. All comments offered at the listening session are welcome and will be considered, including topics covered at previous sessions. Feedback on the following topics is particularly encouraged.
- Opportunities to improve IBC functions and advance transparency
- Roles and responsibilities of institutions, IBCs, investigators, and NIH to strengthen compliance and transparency
- Ways to strengthen coordination between IBCs and other institutional review bodies (e.g., Institutional Animal Care and Use Committees)
- Infrastructure and communication
- Liaison members between committees
- Options for review and approval of lowering requests
- Requests to lower containment for research involving RG3 or RG4 agents or conducted at BL3 or BL4
- NIH review and approval of all requests
- NIH review and approval of initial request, then eligible for IBCs to approve subsequent requests after risk assessment of specific experiments
- Requests to lower containment from BL2 to BL1
- NIH review and approval
- IBC review and approval
Registration
Registration for this event is now closed